S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells

Metastatic melanoma is one of the most aggressive and drug-resistant cancers with very poor overall survival. Circulating melanoma cells (CMCs) were first described in 1991. However, there is no general consensus on the clinical utility of CMC detection, largely due to conflicting results linked to...

Full description

Bibliographic Details
Main Authors: Laure Cayrefourcq, Aurélie De Roeck, Caroline Garcia, Pierre-Emmanuel Stoebner, Fanny Fichel, Françoise Garima, Françoise Perriard, Jean-Pierre Daures, Laurent Meunier, Catherine Alix-Panabières
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/7/755